Effects of body mass index (BMI) and smoking on the pharmacokinetics of fentanyl
Completed
- Conditions
- All patients using a stable dose of a fentanyl (Durogesic ®) patch (for at least 8 days).
- Registration Number
- NL-OMON28290
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
•age > 18 years;
•stable use and dose of fentanyl patch (Durogesic ®) for at least 8 days, irrespective of the dose used;
Exclusion Criteria
•Using fentanyl as rescue medication (other opioids are allowed)
•Serious psychiatric illness, confusion of intellectual disability
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study parameters/endpoints. Pharmacokinetics (clearance, AUC etc)<br>
- Secondary Outcome Measures
Name Time Method not applicable